Skip to main content
Clinical Trials/NCT06592430
NCT06592430
Not yet recruiting
Not Applicable

The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

Shanghai Pulmonary Hospital, Shanghai, China0 sites2,000 target enrollmentOctober 1, 2024
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Enrollment
2000
Primary Endpoint
Overall survival (OS)
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The use of smartphone-based WeChat applications offers significant advantages in cancer patient education, rehabilitation monitoring, and postoperative symptom management. Through the WeChat platform, patients can access health education materials, engage in online consultations, and interact with doctors and other patients at any time. This ongoing education and psychological support help alleviate patient anxiety and improve their quality of life. This study aims to conduct a prospective observational study in our hospital to explore the impact of WeChat communication on the prognosis of patients with different histological types and stages of lung cancer.

Registry
clinicaltrials.gov
Start Date
October 1, 2024
End Date
October 1, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Responsible Party
Principal Investigator
Principal Investigator

Peng Zhang

Professor

Shanghai Pulmonary Hospital, Shanghai, China

Eligibility Criteria

Inclusion Criteria

  • (1) Lung cancer patients receiving treatment at Shanghai Pulmonary Hospital (2) ECOG performance status of 0-2 (3) No other serious internal medical conditions (such as severe heart failure, hypertensive crisis, diabetic ketoacidosis, severe liver or kidney impairment, etc.) (4) No history of other malignant tumors in the past 5 years, and no detection of other tumor history during follow-up after lung cancer diagnosis (5) Relevant pathological results

Exclusion Criteria

  • (1) Patients refused enrollment in this study; (2)Patients refused follow-up.

Outcomes

Primary Outcomes

Overall survival (OS)

Time Frame: 5 years

It is defined as the time (years) frome enrollment to death of participants due to an cause. In the case of a patient who still survives at the time of analysis, the date of last contact will be taken as the censoring date.

Similar Trials